Skip to Main Content
Contact Us
Category: Regulatory
Profiles of Our Network of Oncology Drug Development Experts Our network offers specialized consulting solutions by listening to your needs and offering flexible solutions. Read Now Graphic with blues and purples with a white computer icon in the center surrounded by a circle. Ensuring Flexibility when Approaching CTIS When Catalyst Oncology implements the European Union Clinical Trial Regulation (EU CTR) across Sponsor studies Read Now A smiling Keya Watkins gesturing at a podium at Clinical Trials in Oncology. Navigating the Changing Landscape of Clinical Trials Takeaways from the Clinical Trials in Oncology East Coast I was thrilled to recently chair Read Now Policy Changes from Patient Support to Location BIO International 2024 Highlights Biotech companies from all over the globe, including those researching novel, Read Now Expanding Clinical Trial Diversity: A Catalyst Values Approach “Today, overall cancer clinical trial enrollment in the United States is 8% (6.3%‐7.0% at community Read Now Title graphic for A Reflection on the European Regulatory Framework A Reflection on the European Regulatory Framework Historically gaining regulatory approval across multiple countries within the European Union (EU) was segmented, excessively Read Now Close up of colorful pills Catalyst is Project Optimus ready, are you? What is Project Optimus? Project Optimus, an initiative from the FDA, seeks to optimize dosing. Read Now
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.